P. aeruginosa is one of the complex targets for antimicrobial chemotherapy. Also, it is intrinsically resistant to several antibiotics. It produces β-lactamases enzymes that are responsible for the widespread β-lactam antimicrobial resistance. There are three major groups of β-lactamase enzymes, MBLs and ESBLs forming Pseudomonas is a major issue for the treatment of burns victims. Methods: A total of 28 clinical isolates related to P. aeruginosa have been obtained from the burns specimens from patients attending to AL-Imam hospital/Baghdad-Iraq, through the period from October 2015 to March 2016. Also, all isolates have been recognized as P. aeruginosa via utilizing bacteriological assay and confirmed by Vitek 2. In addition, the susceptibility regarding P. aeruginosa isolates towards many antibiotics is identified detected. Results: it was found that the susceptibility regarding P. aeruginosa isolates towards ceftazidime and cefotaxime respectively is (75%) and (71.4%), while P. aeruginosa isolates’ susceptibility towards imipenem was (67.9%). Extended-spectrum β-lactamases producing Pseudomonas was (30 %) while metallo β-lactamases producing P. aeruginosa was (78.9 %) by double-disk synergy test, in general, the percentage of P. aeruginosa producing ESBL and MBL was (11.1%). Production of EXBLs and MBLs was determined to be plasmid-mediated that could be eliminated by using UV light as a curing agent. Conclusion: The importance of MBL and ESBL forming P. aeruginosa as evidence of increasing resistance to the antimicrobial agent; especially penicillins and cephalosporins as a drug of choice, also it was noticed that P. aeruginosa have the ability to produce MBLs more than ESBL; and these enzymes producing genes are harbored on a plasmid that can be affected by curing chemical agent